Unknown

Dataset Information

0

Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma.


ABSTRACT: BACKGROUND:Periampullary adenocarcinomas, including pancreatic cancer, are a heterogeneous group of tumors with poor prognosis, where classification into intestinal type (I-type) or pancreatobiliary type (PB-type) is a relevant prognostic factor. The clinical significance of deficient mismatch repair (dMMR) in periampullary adenocarcinoma is comparatively unexplored. Herein, we examined the associations of MMR immunophenotype with long-term survival in patients with resected periampullary adenocarcinoma, with particular reference to morphology and adjuvant treatment response. METHODS:MMR protein expression was assessed by immunohistochemistry on tissue microarrays with primary tumors from a retrospective cohort of 175 patients with periampullary adenocarcinoma treated with pancreaticoduodenectomy during 2001-2011 in Malmö and Lund University Hospitals, Sweden. Cox proportional hazards models were applied to calculate hazard ratios (HR) and 95% confidence intervals (CI). RESULTS:After a mean follow-up of 46.5 (1.9-185.1) months, 35 patients (20.3%) were alive, 24 with I-type and 11 with PB-type tumors. MMR protein expression could be evaluated in 172 cases, in which dMMR was denoted in 20 (11.6%) cases, 13/63 (20.6%) in I-type and 7/109 (6.4%) in PB-type tumors. dMMR was associated with a significantly prolonged overall survival in the entire cohort (HR?=?0.28, 95% CI 0.13-0.57), and in I-type tumors (HR?=?0.20, 95% CI 0.06-0.68), however not independent of conventional prognostic factors. In PB-type tumors, dMMR was not prognostic, but there was a significant negative interaction between dMMR and adjuvant treatment (pinteraction?=?0.015). CONCLUSIONS:dMMR is more frequent in I-type compared to PB-type periampullary adenocarcinoma, and is a prognostic factor for long-term survival only in the former. The finding of the small number of PB-type tumors with dMMR potentially lacking benefit from adjuvant chemotherapy is however noteworthy and merits further validation.

SUBMITTER: Heby M 

PROVIDER: S-EPMC5853113 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma.

Heby Margareta M   Lundgren Sebastian S   Nodin Björn B   Elebro Jacob J   Eberhard Jakob J   Jirström Karin K  

Journal of translational medicine 20180314 1


<h4>Background</h4>Periampullary adenocarcinomas, including pancreatic cancer, are a heterogeneous group of tumors with poor prognosis, where classification into intestinal type (I-type) or pancreatobiliary type (PB-type) is a relevant prognostic factor. The clinical significance of deficient mismatch repair (dMMR) in periampullary adenocarcinoma is comparatively unexplored. Herein, we examined the associations of MMR immunophenotype with long-term survival in patients with resected periampullar  ...[more]

Similar Datasets

| S-EPMC7452109 | biostudies-literature
| S-EPMC8339709 | biostudies-literature
2024-09-30 | GSE250445 | GEO
| S-EPMC6425870 | biostudies-literature
| S-EPMC5422112 | biostudies-literature
| S-EPMC9949550 | biostudies-literature
| S-EPMC6776797 | biostudies-literature
| S-EPMC4941418 | biostudies-literature
| S-EPMC5856632 | biostudies-literature
| S-EPMC10782213 | biostudies-literature